Cytek Biosciences boosts its support for scientists in COVID-19 fight

April 30, 2020

Cytek Biosciences is supporting researchers and clinicians who are studying the effect of COVID-19 on human immune systems around the world, collaborating with over a dozen hospitals, medical schools, and university labs.

Cell analysis instrumentation and solutions provider Cytek Biosciences (Fremont, CA) is supporting researchers and clinicians who are studying the effect of COVID-19 on human immune systems around the world, collaborating with over a dozen hospitals, medical schools, and university labs. The scientists at these institutions are working to lessen the health toll of COVID-19 through immune monitoring, biomarker identification, and vaccine development.

Cytek's scientific application experts are assisting in optimizing high-parameter multicolor panels, as well as offering guidance with data QC and analysis. The company's field service staff are prioritizing sites running COVID-19 patient studies to ensure their cell analyzers are performing optimally and their experiments continue uninterrupted. Finally, its operations are maintaining all these field activities by keeping the supply chain running, ensuring existing instruments have the necessary replacement parts and building additional instruments for installation at sites conducting critical research studies.

Cytek hosted a webinar at 10 a.m. PDT on Thursday, April 30, 2020, detailing how high-quality, high-complexity multicolor flow cytometry panels developed on the Cytek Aurora flow cytometer can be leveraged for researching the immune response to COVID-19.

For more information, please visit cytekbio.com.